You have 9 free searches left this month | for more free features.

Condition

Non-Small Cell Lung Cancer (2)

Advanced Solid Tumors (1)

Colorectal Cancer (1)

Metastatic Colorectal Cancer (1)

Overall Status

Recruiting (3)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Hoffmann-La Roche (2)

Genentech, Inc. (1)

Collaborator

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

gdc-6036

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC Trial in Busan (GDC-6036, Pembrolizumab)

Recruiting

Non-Small Cell Lung Cancer

GDC-6036
Pembrolizumab

Busan, Korea, Republic of

Pusan National University Hospital

Apr 3, 2023

NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)

Recruiting

Non-Small Cell Lung Cancer
+2 more

GDC-6036
+6 more

Duarte, California
+68 more

Jan 10, 2023

Metastatic Colorectal Cancer Trial in Worldwide (Inavolisib, Bevacizumab, Cetuximab)

Recruiting

Metastatic Colorectal Cancer

Inavolisib
+7 more

Birmingham, Alabama
+36 more

Dec 29, 2022